← FDA Drug Approvals (Drugs@FDA)
EMPAGLIFLOZIN; LINAGLIPTIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ANNORA PHARMA · Approved 2021-03-30
Drug application
- FDA Application #
ANDA212364- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- EMPAGLIFLOZIN; LINAGLIPTIN
- Generic name
- Empagliflozin
- Active ingredients
- EMPAGLIFLOZIN; LINAGLIPTIN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- ANNORA PHARMA
- First approval
- 2021-03-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown